BackgroundCheck.run
Search For

Michael Pa Pollastri, 51Frye Island, ME

Michael Pollastri Phones & Addresses

Raymond, ME   

Portland, ME   

373 Newton St, Waltham, MA 02453    781-8910131   

45 Chestnut St, Waltham, MA 02453   

235 Pond St, Cohasset, MA 02025    781-4547477   

Rindge, NH   

Durham, NC   

Madison, CT   

Niantic, CT   

Social networks

Michael Pa Pollastri

Linkedin

Work

Company: Northeastern university Feb 2020 Position: Academic lead for the roux institute

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Brown University 2000 to 2004 Specialities: Organic Chemistry

Skills

Medicinal Chemistry • Drug Discovery • Organic Synthesis • Chemistry • Organic Chemistry • Analytical Chemistry • Purification • Drug Design • Molecular Modeling • Technology Transfer • Technology Development • Scientific Writing

Industries

Higher Education

Mentions for Michael Pa Pollastri

Michael Pollastri resumes & CV records

Resumes

Michael Pollastri Photo 12

Academic Lead For The Roux Institute

Location:
Portland, ME
Industry:
Higher Education
Work:
Northeastern University
Academic Lead For the Roux Institute
Brandeis University May 2006 - Dec 2011
Instructor
Boston University Oct 2007 - Aug 2009
Research Assistant Professor
Pfizer Oct 2003 - Oct 2007
Principal Scientist - Chemistry
Pfizer Feb 1998 - Oct 2003
Associate Scientist
Education:
Brown University 2000 - 2004
Doctorates, Doctor of Philosophy, Organic Chemistry
Duke University 1995 - 1998
Master of Science, Masters, Organic Chemistry
College of the Holy Cross 1991 - 1995
Bachelors, Bachelor of Arts, Chemistry
Oakmont Hs 1983 - 1991
Skills:
Medicinal Chemistry, Drug Discovery, Organic Synthesis, Chemistry, Organic Chemistry, Analytical Chemistry, Purification, Drug Design, Molecular Modeling, Technology Transfer, Technology Development, Scientific Writing

Publications & IP owners

Us Patents

Aryl Hydrocarbon Receptor (Ahr) Modifiers As Novel Cancer Therapeutics

US Patent:
2013028, Oct 24, 2013
Filed:
Jul 27, 2011
Appl. No.:
13/812375
Inventors:
David H. Sherr - West Roxbury MA, US
Michael Pollastri - Waltham MA, US
Jennifer Schlezinger - East Falmouth MA, US
Sarah Haigh Molina - Boston MA, US
Scott Schaus - Boston MA, US
Joshua Robert Giguere - Sharon MA, US
Assignee:
TRUSTEES OF BOSTON UNIVERSITY - Boston MA
BOSTON MEDICAL CENTER CORPORATION - Boston MA
NORTHEASTERN UNIVERSITY - Boston MA
International Classification:
C07D 311/22
C07D 407/04
US Classification:
514456, 549400, 435 29
Abstract:
Provided herein are novel agents that modulate AhR activity for use in therapeutic compositions and methods thereof for inhibiting cancer cell proliferation and tumor cell invasion and metastasis. The agents comprise AhR inhibitors or non-constitutive AhR agonists of Formula (I) and (II) for the inhibition of cancer cell growth and parameters that characterize tumor metastasis, such as tumor cell invasiveness.

Antiparasitic Agents Based On Mtor Inhibitors

US Patent:
2013029, Nov 7, 2013
Filed:
Jul 11, 2011
Appl. No.:
13/808892
Inventors:
Michael P. Pollastri - Waltham MA, US
Miguel Navarro - Granada, ES
Stephen Beverley - St. Louis MO, US
Ana Rodriguez - New York NY, US
International Classification:
A61K 31/5377
A61K 31/519
A61K 31/496
A61K 31/4745
US Classification:
5142325, 514293, 5142621, 5142335, 51425411, 5142328, 5142342, 5142332, 514267
Abstract:
Disclosed is the use of mammalian target of rapamycin (mTOR) and/or phosphoinositide-3-kinase (PI3K) inhibitors as antiparasitic drugs, particularly in those parasitic infections caused by trypanosomatid parasites {sp. and sp.). These inhibitors are useful as trypanocides.

Methods Of Eradicating Bacterial Cell Populations

US Patent:
2014003, Jan 30, 2014
Filed:
Oct 1, 2013
Appl. No.:
14/043362
Inventors:
Kim LEWIS - Newton MA, US
Brian CONLON - Boston MA, US
Mark L. NELSON - Norfolk MA, US
Michael P. POLLASTRI - Waltham MA, US
Thomas A. DAHL - Madison CT, US
Assignee:
NORTHEASTERN UNIVERSITY - Boston MA
International Classification:
A61K 31/437
A61K 31/5377
A61K 31/343
US Classification:
514 28, 514287, 5142368
Abstract:
Disclosed herein are methods and compositions for the eradication of bacterial infections. In particular, methods and compositions are disclosed for the eradication of persister and slow growing bacterial cell populations. In particular embodiments, the methods and compositions disclosed herein are useful for eradication of biofilms.

Quinoline And Quinoxaline Compounds

US Patent:
2006012, Jun 8, 2006
Filed:
Dec 15, 2005
Appl. No.:
11/305874
Inventors:
Bruce Bechle - Oakdale CT, US
George Chang - Old Saybrook CT, US
Jari Finneman - Salem CT, US
Ravi Garigipati - South Glastonbury CT, US
Rayn Kelley - Groton CT, US
David Perry - Mystic CT, US
Michael Pollastri - Waltham MA, US
Roger Ruggeri - Waterford CT, US
International Classification:
A61K 31/47
C07D 215/38
US Classification:
514311000, 546169000
Abstract:
Quinoline and quinoxaline compounds, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.

Public records

Vehicle Records

Michael Pollastri

Address:
373 Newton St, Waltham, MA 02453
Phone:
781-4547477
VIN:
5J6YH27397L011847
Make:
HONDA
Model:
ELEMENT
Year:
2007

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.